A Study of AK131 in Patients With Advanced Solid Tumors
Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 1
Recruiting
Sponsor: Akeso
No Placebo Group
Trial Summary
What is the purpose of this trial?
This is a phase Ia/Ib study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of AK131 in advanced solid tumor patients
Research Team
Eligibility Criteria
Inclusion Criteria
If you could have a baby, you must use protection during the study and for 120 days after the study ends.
You need to agree in writing to take part in the study after learning about it.
You are able to carry out your daily activities without any help, or with little help.
See 4 more
Treatment Details
Participant Groups
1Treatment groups
Experimental Treatment
Group I: AK131Experimental Treatment1 Intervention
Subjects will receive AK131 via intravenously (IV) Q2W or Q3W, up to 2 years
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Loading ...
Who Is Running the Clinical Trial?
Akeso
Lead Sponsor
Trials
122
Patients Recruited
23,400+